The FDA on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug ...

Eli Lilly and Co. CEO David Ricks—IBJ’s newsmaker ... The new funding will bring the Indianapolis-based drugmaker’s total investment in the Boone County site to more than $13 billion ...

Eli Lilly and Co. said in October it will invest ... The new funding will bring the Indianapolis-based drugmaker’s total investment in the Lebanon site to $13.5 billion, making the development ...

The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.

Christmas has come early for Eli Lilly this year, courtesy of a fresh FDA approval for the Indianapolis drugmaker’s obesity ...

The scholarship will pay for 4 years of tuition, fees and books at an Indiana public or private nonprofit college or ...

The FDA has approved Eli Lillys Zepbound as the first weight-loss drug to treat obstructive sleep apnea, reshaping care for ...

Lilly also announced other multibillion-dollar manufacturing expansion projects near its Indianapolis headquarters earlier this year. Eli Lilly and Co. said Thursday that it has slated more than $ ...

With Eli Lilly's diabetes and obesity products Mounjaro ... What to do with all that cash? One answer: the Indianapolis-based pharma giant on Monday laid out a plan for a board-approved share ...